Fulcrum Therapeutics Inc (NAS:FULC)
$ 4.79 -0.05 (-1.03%) Market Cap: 258.37 Mil Enterprise Value: 12.97 Mil PE Ratio: 0 PB Ratio: 1.00 GF Score: 50/100

Q2 2022 Fulcrum Therapeutics Inc Earnings Call Transcript

Aug 11, 2022 / 12:00PM GMT
Release Date Price: $7.57 (-2.45%)
Operator

Good morning and welcome to the Fulcrum Therapeutics Second Quarter 2022 Conference Call. (Operator Instructions) Please note today's conference is being recorded.

I would now like to turn the call over to Stephanie Ascher from Stern Investor Relations. Please proceed.

Stephanie Baritz Ascher
Stern Investor Relations, Inc. - SVP

Thank you, Rocco. Good morning and welcome to the Fulcrum Therapeutics conference call. Please be reminded that remarks made during this call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These may include statements about our future expectations and plans, clinical development time lines and financial projections.

While these forward-looking statements represent our views as of today, they should not be relied upon as representing our views in the future. We may update these statements in the future, but we are not taking on an obligation to do so.

Please refer to our most recent filings with the Securities and Exchange Commission for a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot